Company Overview
Company Type: Private Company
Website: innovaderm.com
Number of Employees: -
Year Founded: 2000
Total Amount Raised (CAD mm)†: -
Total Rounds of Funding**:-
Latest Post-Money Valuation ($ mm) -
Latest Pre-Money Valuation ($ mm) -
† This number reflects the estimated value of the total new money raised through private placement rounds.
** This value is an estimate of the total number of funding rounds this company has received.


Business Description
Innovaderm Research Inc., a clinical research organization, provides clinical research services to discover new dermatology therapies. The company was founded in 2000 and is based in Montreal, Canada.


Financial Information (Currency: CAD, in mm)
Total Revenue
-
Operating Income
-
Total Assets
-
Gross Profit
-
EBITDA
-
Total Debt
-
Net Income
-
Estimated Number of Employees
-
Net Debt
-
* Hover over data point numbers for date and source.

Key Professionals
No Key Professionals have been profiled.


Primary Industry Classification
Life Sciences Tools and Services


Primary Office Location
3530 Saint-Laurent boulevard Suite 300 | Montreal, QC | H2X 2V1 | Canada
Fax: 514 521 4175


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Current and Pending Subsidiaries / Investments
Company Name
Business Description
Geography
Primary Industry
LTM Total Rev.($mm)
LFQ Total Assets ($mm)
LFQ Total Debt ($mm)
Excelsus Statistics Inc.
Excelsus Statistics Inc. provides biostatistical and statistical analysis system programming services. The company was incorporated in 2012 and is based in Montreal, Canada. As of July 5, 2022, Excelsus Statistics Inc. operates as a subsidiary of Innovaderm Research Inc.

United States and Canada
Life Sciences Tools and Services
-
-
-


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Jul-05-2022
Jul-05-2022
Merger/Acquisition
Buyer
Excelsus Statistics Inc.
Innovaderm Research Inc.

-
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Jun-19-2023
Executive/Board Changes - Other
Innovaderm Research, Inc. Appoints Cedric Burg as New Chief Operating Officer
Jul-28-2022
Business Expansions
Innovaderm Research Inc. Bolsters European Presence with Two Newly-Established Operations Hubs (Spain & Poland)
Jul-05-2022
M&A Transaction Closings
Innovaderm Research Inc. acquired Excelsus Statistics Inc.
Sep-30-2021
Company Conference Presentations
Innovaderm Research Inc. Presents at 30th European Academy of Dermatology and Venereology Congress, Sep-30-2021 03:15 PM
Jan-24-2010
Company Conference Presentations
Innovaderm Research Inc. Presents at BioPartnering North America, Jan-24-2010

M&A Advisors
Fasken Martineau DuMoulin LLP


Advisors
M&A Advisors
Fasken Martineau DuMoulin LLP


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
GlobalData

Sep 22, 2023 06:20 AM
Innovaderm Research Inc.
Innovaderm Research Inc
Reports
87
GlobalData

Jun 15, 2023 02:12 AM
Innovaderm Research Inc.
Innovaderm Research Inc
Reports
84
GlobalData

Mar 16, 2023 03:42 AM
Innovaderm Research Inc.
Innovaderm Research Inc
Reports
71
GlobalData

Dec 15, 2022 12:16 AM
Innovaderm Research Inc.
Innovaderm Research Inc
Reports
72
GlobalData

Sep 19, 2022 08:43 AM
Innovaderm Research Inc.
Innovaderm Research Inc
Reports
59
GlobalData

Jun 16, 2022 01:05 AM
Innovaderm Research Inc.
Innovaderm Research Inc
Reports
48
GlobalData

Mar 16, 2022 03:55 AM
Innovaderm Research Inc.
Innovaderm Research Inc
Reports
48
GlobalData

Dec 14, 2021 01:28 AM
Innovaderm Research Inc.
Innovaderm Research Inc
Reports
45
GlobalData

Sep 17, 2021 08:29 AM
Innovaderm Research Inc.
Innovaderm Research Inc
Reports
44
GlobalData

Jun 14, 2021 01:40 PM
Innovaderm Research Inc.
Innovaderm Research Inc
Reports
43


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.

Key Executives and Professionals Details
No Key Executives and Professionals exist.

S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 
